• ISSN 1674-8301
  • CN 32-1810/R
Volume 34 Issue 6
Nov.  2020
Turn off MathJax
Article Contents
Chen Wei, Hu Zhiliang, Yi Changhua, Chi Yun, Xiong Qingfang, Tan Chee Wah, Yi Yongxiang, Wang Lin-Fa. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report[J]. The Journal of Biomedical Research, 2020, 34(6): 470-474. doi: 10.7555/JBR.34.20200099
Citation: Chen Wei, Hu Zhiliang, Yi Changhua, Chi Yun, Xiong Qingfang, Tan Chee Wah, Yi Yongxiang, Wang Lin-Fa. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report[J]. The Journal of Biomedical Research, 2020, 34(6): 470-474. doi: 10.7555/JBR.34.20200099

An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report

doi: 10.7555/JBR.34.20200099
More Information
  • Corresponding author: Yongxiang Yi, Nanjing infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, 1-1 Zhongfu Road, Nanjing, Jiangsu 210003, China. Tel: +86-25-83626203, E-mail: yongxiangyinj@163.com; Lin-Fa Wang, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore. E-mail: linfa.wang@duke-nus.edu.sg
  • Received: 2020-06-22
  • Revised: 2020-07-20
  • Accepted: 2020-07-22
  • Published: 2020-09-16
  • Issue Date: 2020-11-28
  • The ongoing coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis, causing social and economic disasters in many countries. In China, two-consecutive negative results of nucleic acid tests for SARS-CoV-2 from the respiratory samples are required to end the quarantine of COVID-19 patients. However, clinicians face a dilemma in case of patients with long-term viral shedding. This report described an unusual COVID-19 case who had persistent viral RNA positivity for more than 4 months after initial illness in the presence of low neutralizing antibodies, but without prolonged clinical symptoms. Multiple anti-viral drug treatments had no impact and there was no evidence of re-infection. When the patient was self-quarantined at home, no infection occurred to the three family members living with her for 15 to 19 days. Sputum viral culture in BSL-3 laboratory on the 102nd day after symptom onset was negative. From the 129th day on, 8 continuous nucleic acid tests of sputum samples showed negative results. The patient was discharged on 137th days since symptom onset. In conclusion, viral RNA shedding in the sputum of the COVID-19 patient may last over 4 months. As no evidence shows the existence of infectious virus, two-consecutive negative nucleic acid tests may not be the prerequisite for ending quarantine of COVID-19 patients with prolonged viral shedding.

     

  • loading
  • [1]
    National Health Commission, National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7)[J]. Chin Med J, 2020, 133(9): 1087–1095. doi: 10.1097/CM9.0000000000000819
    [2]
    Lu RJ, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565–574. doi: 10.1016/S0140-6736(20)30251-8
    [3]
    Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test (sVNT) based on antibody-mediated blockage of ACE2-spike (RBD) protein-protein interaction[J]. Nat Biotechnol, 2020, 38(9): 1073–1078. doi: 10.1038/s41587-020-0631-z
    [4]
    He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19[J]. Nat Med, 2020, 26(5): 672–675. doi: 10.1038/s41591-020-0869-5
    [5]
    Qi L, Yang Y, Jiang DX, et al. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study[J]. Int J Infect Dis, 2020, 96: 531–537. doi: 10.1016/j.ijid.2020.05.045
    [6]
    Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019[J]. Nature, 2020, 581(7809): 465–469. doi: 10.1038/s41586-020-2196-x
    [7]
    Zhou F, Yu T, Du RH, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229): 1054–1062. doi: 10.1016/S0140-6736(20)30566-3
    [8]
    Liu WD, Chang SY, Wang JT, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19[J]. J Infect, 2020, 81(2): 318–356. doi: 10.1016/j.jinf.2020.03.063
    [9]
    Gasparyan AY, Misra DP, Yessirkepov M, et al. Perspectives of immune therapy in coronavirus disease 2019[J]. J Korean Med Sci, 2020, 35(18): e176. doi: 10.3346/jkms.2020.35.e176
    [10]
    Shen CG, Wang ZQ, Zhao F, et al. Treatment of 5 Critically Ill patients with COVID-19 with convalescent plasma[J]. JAMA, 2020, 323(16): 1582–1589. doi: 10.1001/jama.2020.4783
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Article Metrics

    Article views (624) PDF downloads(93) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return